MARGARET A. ALEXANDER - President and CEO, Director at Ovid Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
OVID on Nasdaq
All Insider Reports
All Insider Reports

MARGARET A. ALEXANDER - trading volume in the past year for Ovid Therapeutics Inc.

Holdings reported by MARGARET A. ALEXANDER for Ovid Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 61,750 $89,537 $1.45 23 Feb 2026 Direct
Employee Stock Option (Right to Buy) 1,435,000 26 Feb 2026 Direct Common Stock

Transactions reported by MARGARET A. ALEXANDER for Ovid Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.